- Home
- LCUT vs ZNTL Comparison
LCUT vs ZNTL Comparison
Compare LCUT & ZNTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LCUT
- ZNTL
- Stock Information
- Founded
- LCUT 1945
- ZNTL 2014
- Country
- LCUT United States
- ZNTL United States
- Employees
- LCUT N/A
- ZNTL N/A
- Industry
- LCUT Industrial Machinery/Components
- ZNTL Biotechnology: Pharmaceutical Preparations
- Sector
- LCUT Consumer Discretionary
- ZNTL Health Care
- Exchange
- LCUT Nasdaq
- ZNTL Nasdaq
- Market Cap
- LCUT 97.2M
- ZNTL 105.8M
- IPO Year
- LCUT 1991
- ZNTL 2020
- Fundamental
- Price
- LCUT $3.77
- ZNTL $1.45
- Analyst Decision
- LCUT Buy
- ZNTL Buy
- Analyst Count
- LCUT 2
- ZNTL 7
- Target Price
- LCUT $5.50
- ZNTL $8.46
- AVG Volume (30 Days)
- LCUT 20.9K
- ZNTL 776.4K
- Earning Date
- LCUT 11-06-2025
- ZNTL 11-11-2025
- Dividend Yield
- LCUT 4.33%
- ZNTL N/A
- EPS Growth
- LCUT N/A
- ZNTL N/A
- EPS
- LCUT N/A
- ZNTL N/A
- Revenue
- LCUT $670,991,000.00
- ZNTL $26,865,000.00
- Revenue This Year
- LCUT N/A
- ZNTL N/A
- Revenue Next Year
- LCUT $2.43
- ZNTL N/A
- P/E Ratio
- LCUT N/A
- ZNTL N/A
- Revenue Growth
- LCUT N/A
- ZNTL N/A
- 52 Week Low
- LCUT $2.89
- ZNTL $1.01
- 52 Week High
- LCUT $7.05
- ZNTL $5.44
- Technical
- Relative Strength Index (RSI)
- LCUT 41.50
- ZNTL 41.29
- Support Level
- LCUT $3.97
- ZNTL $1.60
- Resistance Level
- LCUT $4.20
- ZNTL $2.02
- Average True Range (ATR)
- LCUT 0.22
- ZNTL 0.13
- MACD
- LCUT -0.01
- ZNTL -0.05
- Stochastic Oscillator
- LCUT 0.00
- ZNTL 6.56
About LCUT Lifetime Brands Inc.
Lifetime Brands Inc is a U.S. based company that designs, sources, and sells branded kitchenware, tableware, and other products used in the home and markets its products under brands such as Farberware, KitchenAid, Mikasa, and others. The company markets and sells its products principally on a wholesale basis to retailers. It also markets and sells a limited selection of its products directly to consumers through its Pfaltzgraff, Mikasa, Fred, and Friends, Built NY, and others. Its products include kitchen tools, gadgets, cutlery, dinnerware, and glassware. The segments of the company are the U.S. and International. It derives a majority of its revenue from the U.S. segment. The company derives maximum revenue from Kitchenware products.
About ZNTL Zentalis Pharmaceuticals Inc.
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.